Literature DB >> 17940951

High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings.

Jonathan S Towner1, Tara K Sealy, Thomas G Ksiazek, Stuart T Nichol.   

Abstract

Within the past dozen years, outbreaks of filoviral hemorrhagic fever within the human population have been occurring with increasing frequency, with an average of 1 epidemic now occurring every 1-2 years. Many of the outbreaks have been large (involving >150 cases), necessitating rapid responses from the international community to help implement infection control and surveillance. This increased activity, combined with today's climate of bioterrorism threats, has heightened the need for high-throughput methodologies for specific detection of these high-hazard viruses in sophisticated laboratory setups and mobile field laboratory situations. Using Zaire Ebola virus as an example, we describe here the development of a high-throughput protocol for RNA extraction and quantitative reverse-transcription polymerase chain reaction analysis that is safe, fast, and reliable. Furthermore, the applicability of this method to an outbreak setting was demonstrated by correct analysis of >500 specimens at a field laboratory established during a recent outbreak of Marburg hemorrhagic fever in Angola.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940951     DOI: 10.1086/520601

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  52 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou
Journal:  Clin Infect Dis       Date:  2016-06-27       Impact factor: 9.079

3.  Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood.

Authors:  Jason W Benzine; Kerry M Brown; Krystle N Agans; Ronald Godiska; Chad E Mire; Krishne Gowda; Brandon Converse; Thomas W Geisbert; David A Mead; Yogesh Chander
Journal:  J Infect Dis       Date:  2016-09-16       Impact factor: 5.226

4.  Successful delivery of RRT in Ebola virus disease.

Authors:  Michael J Connor; Colleen Kraft; Aneesh K Mehta; Jay B Varkey; G Marshall Lyon; Ian Crozier; Ute Ströher; Bruce S Ribner; Harold A Franch
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

Review 5.  Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

Authors:  Chad T Coarsey; Nwadiuto Esiobu; Ramswamy Narayanan; Mirjana Pavlovic; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Microbiol       Date:  2017-04-25       Impact factor: 7.624

6.  Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences.

Authors:  Serena A Carroll; Jonathan S Towner; Tara K Sealy; Laura K McMullan; Marina L Khristova; Felicity J Burt; Robert Swanepoel; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.

Authors:  Paul Roddy; Sara L Thomas; Benjamin Jeffs; Pascoal Nascimento Folo; Pedro Pablo Palma; Bengi Moco Henrique; Luis Villa; Fernando Paixao Damiao Machado; Oscar Bernal; Steven M Jones; James E Strong; Heinz Feldmann; Matthias Borchert
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

8.  Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.

Authors:  Lisa E Hensley; Sabue Mulangu; Clement Asiedu; Joshua Johnson; Anna N Honko; Daphne Stanley; Giulia Fabozzi; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin; Victoria Wahl-Jensen; Michael Bailey; Peter B Jahrling; Mario Roederer; Richard A Koup; Nancy J Sullivan
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

9.  Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.

Authors:  Amy L Hartman; Ling Ling; Stuart T Nichol; Martin L Hibberd
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.

Authors:  Jonathan S Towner; Brian R Amman; Tara K Sealy; Serena A Reeder Carroll; James A Comer; Alan Kemp; Robert Swanepoel; Christopher D Paddock; Stephen Balinandi; Marina L Khristova; Pierre B H Formenty; Cesar G Albarino; David M Miller; Zachary D Reed; John T Kayiwa; James N Mills; Deborah L Cannon; Patricia W Greer; Emmanuel Byaruhanga; Eileen C Farnon; Patrick Atimnedi; Samuel Okware; Edward Katongole-Mbidde; Robert Downing; Jordan W Tappero; Sherif R Zaki; Thomas G Ksiazek; Stuart T Nichol; Pierre E Rollin
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.